We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
59 hedge funds and large institutions have $57.2M invested in CASI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more capital invested
Capital invested by funds: $44.4M → $57.2M (+$12.8M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 58 → 59 (+1)
0.07% more ownership
Funds ownership: 2.2% → 2.27% (+0.07%)
Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
7
Increased
27
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WSC
Wellington Shields & Co
New York
|
+$587K |
| 2 |
BlackRock
New York
|
+$486K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$385K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$348K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$211K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$66.2K |
| 2 |
First Manhattan
New York
|
-$61K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$44K |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$39.2K |
| 5 |
Goldman Sachs
New York
|
-$38K |
